Results 141 to 150 of about 1,308 (200)

Is the Addition of CO₂ Laser to β3-Adrenoceptor Agonist Mirabegron Effective in the Management of Overactive Bladder? Results of a Randomized Controlled Trial. [PDF]

Medicina (Kaunas)
Kypriotis K, Prodromidou A, Athanasiou S, Zacharakis D, Kathopoulis N, Douligeris A, Athanasiou V, Michala L, Grigoriadis T.   +8 more
europepmc   +1 more source

Kabbe condensation: a comprehensive review of spirochromanone synthesis and medicinal applications. [PDF]

RSC Adv
Samandram R, Komarasamy B, Murugan P, Jayaraj P, Vemparala M, Fareed Chaman A, Anaikutti P.   +6 more
europepmc   +1 more source

Pre-Steady-State and Steady-State Kinetic Analysis of Butyrylcholinesterase-Catalyzed Hydrolysis of Mirabegron, an Arylacylamide Drug. [PDF]

Molecules
Shaihutdinova Z, Masson P.
europepmc   +1 more source

Mirabegron treatment reduces myofibroblasts and CXCR2 expression in adipose tissue in obesity. [PDF]

Mol Med
Finlin BS, Memetimin H, Westgate PM, Chen J, Dupont-Versteegden EE, Kern PA.   +5 more
europepmc   +1 more source

An Integrated Review of Pesticides and Antibiotics in Agricultural Environments: Occurrence, Cross-Media Transport, and Plant Uptake. [PDF]

Foods
Li J, Yan Q, Du B, Feng G.
europepmc   +1 more source

Mirabegron nighttime versus daytime dosing for women with overactive bladder syndrome: a randomized controlled trial. [PDF]

Sci Rep
Hsiao SM.
europepmc   +1 more source

7-Methoxybenzofuran-triazole tethered <i>N</i>-phenylacetamides as a promising class of tyrosinase inhibitors: synthesis, biological evaluation and computational analyses against fungal and human tyrosinases. [PDF]

RSC Adv
Mushtaq A, Zahoor AF, Kamal S, Mojzych M, Saif MJ, Bhat MA.   +5 more
europepmc   +1 more source

Drug-induced xerostomia and hyposalivation in patients with overactive bladder: a prospective open-label observational study comparing antimuscarinics and β3-adrenoceptor agonists. [PDF]

Sci Rep
Ostrowska M, Settaf-Cherif L, Kiersztyn J, Ostrowski A, Drewa TA, Adamowicz J, Wróbel MJ.   +6 more
europepmc   +1 more source

Topliss-Guided Optimization of Acetanilide-Based Soluble Epoxide Hydrolase Inhibitors: Exploring the Pentafluorosulfanyl Group as a Potency-Enhancing Motif. [PDF]

ChemMedChem
López-Ruiz A, Pujol E, Ramos C, Rizzo V, Morisseau C, Val C, Ginex T, Vázquez J, Codony S, Turcu AL, Pérez B, Sáez E, Pineda-Lucena A, Hammock BD, Luque FJ, Loza MI, Brea J, Vázquez S.   +17 more
europepmc   +1 more source

Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States. [PDF]

Urology
Enemchukwu EA, Sinclair S, Mohamud H, Zhang CA, Anger JT, Scales CD.   +5 more
europepmc   +1 more source